December 9th, 2021
8:30 – 11:00 (Brasilia time, Brazil)
Chairs: Rafael Franco (University of Barcelona, Spain), Paulo Andrade Lotufo (University of São Paulo)
SESSION 3. SPECIAL SUBPOPULATIONS AND PATIENTS WITH COMORBIDITIES
8:30 am
Speaker: Hongjie Yu (Fudan University, China)
Immunogenicity of CoronaVac among the elderly and pediatric population-based on phase II clinical trials (including booster and persistence)
9:00 am
Speaker: Susan M. Bueno (Pontificia Universidad Católica de Chile)
Safety, Immunogenicity and efficacy of an inactivated SARS-CoV-2 vaccine in the pediatric population in Chile
9:20 am
Speaker: Jiayi Wang (Sinovac, China)
Safety analysis among the pediatric population and population receiving Booster dose in China
9:40 am
Speaker: Eloisa Bonfá (University of São Paulo, Brazil)
PHASE 4 PROSPECTIVE STUDY OF SAFETY AND IMMUNOGENICITY OF CORONAVAC VACCINE IN 910 AUTOIMMUNE RHEUMATIC DISEASES PATIENTS
10:00 am
Speaker: Zijie Zhang (Yunnan University, China)
Safety and immunogenicity of CoronaVac in people with chronic diseases and a third dose in people with low response to primary immunization
10:20 am
General Discussion
11:00 am
Final remarks (chairs)
